Robin Abcarian is an opinion columnist at the Los Angeles Times. She writes about news, politics and culture. Her columns appear on Wednesday and Sunday. Twitter: @AbcarianLAT
Latest From This Author
The former president and his new running mate, J.D. Vance, are running away from the political repercussions of their extreme opposition to abortion rights.
July 21, 2024
Despite partisan accusations by J.D. Vance and others, Thomas Matthew Crooks’ assassination attempt isn’t exceptional in the annals of American firearm violence.
July 17, 2024
A new documentary, ‘Bad Faith,’ explores the racist, reactionary movement driving the success of Donald Trump and being endorsed by the likes of Josh Hawley.
July 14, 2024
Don’t believe the Republican caricatures: Vice President Kamala Harris would be a worthy, historic and formidable candidate to lead the Democratic ticket.
July 10, 2024
Abcarian: The surgeon general acknowledged America’s gun violence emergency. Here’s why that matters
Vivek Murthy’s advisory is a departure from years of denial by the U.S. government. It can only help us treat firearms as the public health crisis they are.
July 3, 2024
Abcarian: Yes, Biden looked and sounded awful. But the debate didn’t change the stark choice we face
The president’s appearance was far worse than the substance of what he said, while Donald Trump offered a forceful presentation of lies and nonsense.
June 28, 2024
After decades of jogging from Venice to Santa Monica, my workout partner took up pickleball, COVID struck and I developed arthritis. I needed a new exercise.
June 26, 2024
Column: Anthony Fauci has a right to savage Trump. His memoir takes a different and telling approach
The physician and researcher who weathered the COVID pandemic, the HIV/AIDS crisis and countless Republican conspiracy theories has a new book.
June 23, 2024
California lawmakers are also considering a measure to keep cellphones out of students’ hands while they’re in class. It’s a great idea.
June 18, 2024
Legislation aimed at unregulated cannabis products containing delta-8 THC could hurt people who use hemp-derived medicine for serious seizures.
June 16, 2024